Airway epithelial damage in premature infants with respiratory failure

R M Lee1, H O'Brodovich

  • 1Department of Anaesthesia, McMaster University, Hamilton, Ontario, Canada.

Insights

Premature infants with respiratory failure show severe airway epithelial damage, particularly in the trachea and bronchi. This damage impairs mucociliary transport, hindering secretion clearance in bronchopulmonary dysplasia.

Area of Science:

  • Neonatal respiratory research
  • Pulmonary pathology
  • Epithelial biology

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
  • Understanding airway epithelial changes is crucial for managing BPD.
  • Previous studies have not fully detailed the evolution of airway damage in neonates with BPD.

Observation:

  • Three premature infants (24-28 wk gestational age) with respiratory failure were studied.
  • Microscopic evaluation of major airways was performed at different time points post-birth (14 hours, 10 days, 6 months).
  • Airway epithelial damage, including denudation and ciliary abnormalities, was assessed.

Findings:

  • Severe tracheal epithelial denudation was observed in all infants.
  • Epithelial damage extended to more distal airways in the infant with established BPD.
  • Ciliary abnormalities were common, and goblet cell percentage decreased distally.
  • The mucociliary transport system appears defective, not excessive secretions, causing clearance issues.

Implications:

  • Assisted ventilation in neonates is linked to significant airway epithelial injury.
  • Defects in mucociliary clearance, not hypersecretion, likely contribute to respiratory complications in BPD.
  • Findings suggest therapeutic targets for improving airway function in premature infants.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...